Sorting live cells using RNA-targeting CRISPR-Cas9 (RCas9)
使用 RNA 靶向 CRISPR-Cas9 (RCas9) 对活细胞进行分选
基本信息
- 批准号:10010549
- 负责人:
- 金额:$ 29.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-03 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAutoimmune DiseasesBindingBioinformaticsBiological AssayBiological SciencesCRISPR/Cas technologyCell Culture TechniquesCell SeparationCell Surface ProteinsCellsClustered Regularly Interspaced Short Palindromic RepeatsDNADahliaDataDeoxyribonuclease IDetectionDevelopmentElectroporationFlow CytometryFluorescenceFluorescence-Activated Cell SortingGenesGoalsGuide RNAHeterogeneityHourImmunooncologyIn VitroIndividualInterferon Type IILengthMagnetismMeasuresMediatingMessenger RNAMethodsMolecularNoiseOligonucleotidesPhasePopulationProteinsProtocols documentationRNAReagentResearchResearch PersonnelRouteScientistSignal TransductionSmall Business Technology Transfer ResearchSorting - Cell MovementSpecificityStainsStem Cell ResearchT-LymphocyteTechniquesTechnologyTestingTimeTranscriptVisionbasebiological researchbiomarker discoverycell typecommercializationcytokinedesigndrug developmentfluorophoreinnovationmRNA Expressionnovelpopulation basedprogramsprotein biomarkersresearch and developmentsample fixationtooltranscriptomicstranslational scientist
项目摘要
Project Summary/Abstract
Transcriptomic-based approaches, and in recent years, single-cell RNA sequencing, are revolutionizing our
understanding of cellular heterogeneity, opening up a new route to identify novel cell markers at
unprecedented scale across many different cell types. RNA-based live-cell sorting opens up >99% of the
marker space to enable higher specificity cell sorting. However, existing methods for cell-based RNA detection
are either incompatible with live cells due to fixation and permeabilization (RNA-FISH) or suffer from poor
signal-to-noise (S/N) and specificity (molecular beacons, SmartFlares). Researchers are currently limited to
purifying cells using antibody-based detection of cell surface protein markers via fluorescence activated cell
sorting (FACS) and magnetic activated cell sorting (MACS). These cell-surface protein markers are often not
always specific enough to isolate important cell subsets as they are also often expressed on non-target cell
types. We propose to develop a robust and easy-to-use live-cell reagent kit leveraging the specificity of
CRISPR-Cas9 to detect RNA in individual cells for FACS-based isolation. While Cas9 is best known as a
programmable sequence-specific DNA endonuclease for gene editing applications, Cas9 can be re-directed to
bind and cut RNA by hybridization of a protospacer-adjacent motif (PAM; a sequence required for Cas9 DNA
cleavage)-containing DNA oligonucleotide (a “PAMmer”) to the target RNA (RCas9). By modifying the PAMmer
with a quencher and fluorophore (FQ-PAMmer), we aim to use Cas9’s cleavage activity to release a quencher
(Q) and activate a fluorescent (F) signal in live cells only upon specific Cas9 guide RNA-mediated binding of
target RNA. While our technology platform is broadly applicable to theoretically any RNA target, our
proof-of-principle studies will be focused on the isolation of a specific T cell subpopulation expressing IFNG
mRNA. The objective of this Phase I STTR project is to demonstrate isolation of live IFNG mRNA+ T cells with
FACS from heterogeneous T cell cultures. The project is organized in two aims to first identify candidate
RCas9 FQ-PAMmer probes targeting the length of the IFNG mRNA transcript with high S/N in vitro and
stability in live cells (Aim 1), then test the RCas9 FQ-PAMmer reagents in live cells and demonstrate isolation
of live IFGN mRNA+ T cells via FACS (Aim 2). Commercialization of Dahlia Biosciences’ live-cell detection
reagent kits will provide a critical tool to research and drug development scientists to isolate and characterize
functionally important rare cell populations, including T cells.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mitchell O'Connell其他文献
Mitchell O'Connell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mitchell O'Connell', 18)}}的其他基金
Multiplexed CRISPR-based immune cell RNA profiling by flow and mass cytometry
通过流式和质谱流式细胞术进行基于 CRISPR 的多重免疫细胞 RNA 分析
- 批准号:
10156088 - 财政年份:2020
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
10160925 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
10384376 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
9796943 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
10406924 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
10581919 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
Programmable RNA-targeting CRISPR-Cas tools to study RNA biology
用于研究 RNA 生物学的可编程 RNA 靶向 CRISPR-Cas 工具
- 批准号:
10621954 - 财政年份:2019
- 资助金额:
$ 29.91万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别: